PL379701A1 - Weterynaryjny wodny roztwór zawiesiny zawierajacy Florfenicol do wykonywania iniekcji - Google Patents
Weterynaryjny wodny roztwór zawiesiny zawierajacy Florfenicol do wykonywania iniekcjiInfo
- Publication number
- PL379701A1 PL379701A1 PL379701A PL37970104A PL379701A1 PL 379701 A1 PL379701 A1 PL 379701A1 PL 379701 A PL379701 A PL 379701A PL 37970104 A PL37970104 A PL 37970104A PL 379701 A1 PL379701 A1 PL 379701A1
- Authority
- PL
- Poland
- Prior art keywords
- florfenicol
- veterinary
- aqueous injectable
- injectable suspensions
- suspensions containing
- Prior art date
Links
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 title abstract 3
- 229960003760 florfenicol Drugs 0.000 title abstract 3
- 239000000725 suspension Substances 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000011203 antimicrobial therapy Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03017323A EP1502589B1 (en) | 2003-07-31 | 2003-07-31 | Veterinary aqueous injectable suspensions containing florfenicol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL379701A1 true PL379701A1 (pl) | 2006-11-13 |
| PL223349B1 PL223349B1 (pl) | 2016-10-31 |
Family
ID=33522319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL379701A PL223349B1 (pl) | 2003-07-31 | 2004-07-30 | Weterynaryjny wodny roztwór zawiesiny zawierający florfenikol do wykonywania iniekcji |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8362087B2 (pl) |
| EP (1) | EP1502589B1 (pl) |
| CN (1) | CN1829503B (pl) |
| AT (1) | ATE327745T1 (pl) |
| AU (1) | AU2004262501B2 (pl) |
| CA (1) | CA2532755C (pl) |
| DE (1) | DE60305687T2 (pl) |
| DK (1) | DK1502589T3 (pl) |
| ES (1) | ES2266695T3 (pl) |
| PL (1) | PL223349B1 (pl) |
| PT (1) | PT1502589E (pl) |
| SI (1) | SI1502589T1 (pl) |
| WO (1) | WO2005013959A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091171A1 (es) * | 2007-12-14 | 2009-08-03 | Schering Plough Ltd | Proceso para recuperar florfenicol y analogos de florfenicol |
| RU2397753C1 (ru) * | 2009-05-12 | 2010-08-27 | Общество с ограниченной ответственностью "Алвис" | Композиция для лечения бактериальных инфекций у животных |
| EP2663582B1 (en) | 2011-01-13 | 2018-07-11 | Austin Research Labs Corp. | High load dispersions for treating infections |
| ES2621304T3 (es) | 2011-03-10 | 2017-07-03 | Xeris Pharmaceuticals, Inc. | Formulaciones estables para inyección parenteral de fármacos peptídicos |
| DK2773331T3 (en) | 2011-10-31 | 2016-03-14 | Xeris Pharmaceuticals Inc | Formulations for the treatment of diabetes |
| US9125805B2 (en) * | 2012-06-27 | 2015-09-08 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of small molecule drugs |
| CN102920655A (zh) * | 2012-11-26 | 2013-02-13 | 哈尔滨市华农威普动物保健品有限公司 | 氟苯尼考混悬注射液及其制备工艺 |
| US9018162B2 (en) | 2013-02-06 | 2015-04-28 | Xeris Pharmaceuticals, Inc. | Methods for rapidly treating severe hypoglycemia |
| CN103145594B (zh) * | 2013-03-26 | 2014-12-17 | 四川农业大学 | 一种制备氟苯尼考微晶体的方法 |
| JP6982495B2 (ja) | 2014-08-06 | 2021-12-17 | ゼリス ファーマシューティカルズ インコーポレイテッド | ペーストの皮内および／または皮下注射のためのシリンジ、キット、および方法 |
| US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
| US11590205B2 (en) | 2015-09-25 | 2023-02-28 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
| JP7299166B2 (ja) | 2017-06-02 | 2023-06-27 | ゼリス ファーマシューティカルズ インコーポレイテッド | 沈殿抵抗性低分子薬物製剤 |
| AT519742B1 (de) * | 2017-09-22 | 2018-10-15 | Rene Weilharter | Schusswaffe |
| CN108904442B (zh) * | 2018-08-09 | 2021-04-06 | 山西瑞象生物药业有限公司 | 一种氟苯尼考溶液剂及其制备方法 |
| CN108863864B (zh) * | 2018-08-16 | 2020-07-24 | 天津大学 | 一种氟苯尼考-柠檬酸共晶及其制备方法 |
| KR102199186B1 (ko) * | 2019-02-13 | 2021-01-06 | 주식회사 이글벳 | 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
| FR2560613B2 (fr) * | 1983-05-16 | 1987-03-27 | Pechiney Aluminium | Perfectionnement aux barres cathodiques comportant une semelle metallique, pour cuves d'electrolyse hall-heroult |
| US5082863A (en) * | 1990-08-29 | 1992-01-21 | Schering Corporation | Pharmaceutical composition of florfenicol |
| US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
| US6074657A (en) * | 1997-03-20 | 2000-06-13 | Pharmacia & Upjohn Company | Administration of an injectable antibiotic in the ear of an animal |
| US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
-
2003
- 2003-07-31 AT AT03017323T patent/ATE327745T1/de active
- 2003-07-31 DE DE60305687T patent/DE60305687T2/de not_active Expired - Lifetime
- 2003-07-31 EP EP03017323A patent/EP1502589B1/en not_active Expired - Lifetime
- 2003-07-31 PT PT03017323T patent/PT1502589E/pt unknown
- 2003-07-31 SI SI200330384T patent/SI1502589T1/sl unknown
- 2003-07-31 ES ES03017323T patent/ES2266695T3/es not_active Expired - Lifetime
- 2003-07-31 DK DK03017323T patent/DK1502589T3/da active
-
2004
- 2004-07-30 CN CN2004800219051A patent/CN1829503B/zh not_active Expired - Fee Related
- 2004-07-30 AU AU2004262501A patent/AU2004262501B2/en not_active Ceased
- 2004-07-30 US US10/566,356 patent/US8362087B2/en not_active Expired - Fee Related
- 2004-07-30 WO PCT/EP2004/008587 patent/WO2005013959A1/en not_active Ceased
- 2004-07-30 PL PL379701A patent/PL223349B1/pl unknown
- 2004-07-30 CA CA2532755A patent/CA2532755C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1502589B1 (en) | 2006-05-31 |
| US8362087B2 (en) | 2013-01-29 |
| EP1502589A1 (en) | 2005-02-02 |
| ES2266695T3 (es) | 2007-03-01 |
| AU2004262501A1 (en) | 2005-02-17 |
| PL223349B1 (pl) | 2016-10-31 |
| ATE327745T1 (de) | 2006-06-15 |
| CA2532755A1 (en) | 2005-02-17 |
| SI1502589T1 (sl) | 2006-12-31 |
| CN1829503B (zh) | 2010-06-23 |
| DK1502589T3 (da) | 2006-09-25 |
| DE60305687D1 (de) | 2006-07-06 |
| PT1502589E (pt) | 2006-10-31 |
| US20060223889A1 (en) | 2006-10-05 |
| WO2005013959A1 (en) | 2005-02-17 |
| AU2004262501B2 (en) | 2008-11-20 |
| DE60305687T2 (de) | 2007-02-22 |
| CA2532755C (en) | 2011-10-04 |
| CN1829503A (zh) | 2006-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL379701A1 (pl) | Weterynaryjny wodny roztwór zawiesiny zawierajacy Florfenicol do wykonywania iniekcji | |
| ES2244831T5 (es) | Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| ES2542206T3 (es) | Medicamentos que contienen fluoroquinolonas | |
| WO2005063745A3 (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
| PH12021552788A1 (en) | Stabilized formulations containing anti-angptl3 antibodies | |
| WO2005072343A3 (en) | Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use | |
| KR20090119975A (ko) | 비타민 ｂ12의 안정화 | |
| EP1875910A4 (en) | APPLICATION OF LEVO-ORNIDAZOLE IN THE MANUFACTURE OF A MEDICAMENT AGAINST INFECTION WITH ANAEROBIC BACTERIA | |
| BRPI0507657A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
| TW200835478A (en) | Alkyl gallate pharmaceutical composition | |
| EP2050442A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE | |
| BRPI0416882A (pt) | composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| EP4649940A3 (en) | Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea | |
| WO2006131923A3 (en) | Novel salts of conjugated psychotropic drugs and processes of preparing same | |
| WO2020219645A3 (en) | Methods for reducing the weight loss or increasing the weight of a feline in need thereof | |
| Al-Rubaye | A review of the literature on antimicrobial preservatives: Definition, properties, classification, safety, side effects and antimicrobial effectiveness testing | |
| Dołhań et al. | Stability of ceftiofur sodium and cefquinome sulphate in intravenous solutions | |
| US20030027791A1 (en) | Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using cyclodextrins | |
| US20030005889A1 (en) | Method of improving hatchability of eggs | |
| US7122201B2 (en) | Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using surfactants and amino acids | |
| KR20140024862A (ko) | 히알루론산 또는 히알루론산염을 포함하는 수용액 | |
| BR0214293A (pt) | Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo | |
| Moreno Herrero et al. | Disulfide oligosaccharide compounds and complexes | |
| EP1059292A3 (en) | New adamantane derivative and aqueous disinfectant composition containing it |